Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
NCT06815250

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Led by Universiti Putra Malaysia · Updated on 2026-05-01

351

Participants Needed

4

Research Sites

19 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The main questions it aims to answer are: Does the InTroDuce-Programme increase knowledge and future intention of pregnant mothers to get vaccinated against Influenza and Tdap? How does demographic factors, attitudes and barriers affect vaccination decisions among pregnant mothers? Researchers will compare InTroDuce-Programme to standard care (routine antenatal care) to see if InTroDuce-Programme works to improve knowledge and future intention of pregnant mothers to be vaccinated against Influenza and Tdap. Participants will: Receive the web-based educational module (InTroDuce-Programme), which covers the importance, safety, and effectiveness of vaccinations, as well as addressing common concerns. Be followed up one month after the intervention. Answer questionnaires before and after the intervention to measure changes in vaccination knowledge and future intention to get vaccinated

CONDITIONS

Official Title

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women aged 18 years and older
  • Before or equal to 32 weeks of gestation as we need to follow-up the patients again at 36 weeks of gestation before delivery occurs.
  • Able to understand and consent to participation in the study.
Not Eligible

You will not qualify if you...

  • Pregnant women with severe anaphylactic or allergic reactions to previous dose of influenza or Tdap vaccination.
  • Non-Malaysian

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Klinik Kesihatan Bangi

Bandar Baru Bangi, Selangor, Malaysia, 43650

Actively Recruiting

2

Klinik Kesihatan Batu 9

Cheras, Selangor, Malaysia, 43200

Actively Recruiting

3

Klinik Kesihatan Balakong

Cheras, Selangor, Malaysia, 43300

Actively Recruiting

4

Klinik Kesihatan Kajang

Kajang, Selangor, Malaysia, 43000

Actively Recruiting

Loading map...

Research Team

H

Hung Chiun Lau, Dr Fam Med

CONTACT

S

Siew Mooi Ching, Fam Med

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here